Cumberland Pharmaceuticals (CPIX) Other Accumulated Expenses (2010 - 2026)

Cumberland Pharmaceuticals (CPIX) has 17 years of Other Accumulated Expenses data on file, last reported at $13.0 million in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses rose 15.67% year-over-year to $13.0 million; the trailing twelve-month figure through Mar 2026 stood at $13.0 million (up 15.67% YoY), and the FY2025 full-year result was $12.6 million, up 3.14% from the prior year.
• Other Accumulated Expenses climbed to $13.0 million in Q1 2026, from $12.6 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $17.6 million in Q4 2022 to a low of $10.1 million in Q3 2025.
• A 5-year average of $13.1 million and a median of $13.0 million in 2026 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses soared 102.9% in 2022 and decreased 24.51% in 2024, its largest moves.
• Tracing CPIX's Other Accumulated Expenses over 5 years: stood at $17.6 million in 2022, then decreased by 22.69% to $13.6 million in 2023, then slipped by 9.9% to $12.3 million in 2024, then rose by 3.14% to $12.6 million in 2025, then rose by 2.72% to $13.0 million in 2026.
• Business Quant data shows CPIX's Other Accumulated Expenses at $13.0 million in Q1 2026, $12.6 million in Q4 2025, and $10.1 million in Q3 2025.